Global and China CRISPR/Cas9 Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.  Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

    This report elaborates on the current development of the CRISPR/Cas9 industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Thermo Fisher Scientific

    • Intellia Therapeutics

    • Editas Medicine

    • Synthego

    • CRISPR Therapeutics

    • Merck

    • Integrated DNA Technologies (IDT)

    • GeneCopoeia

    • Mirus Bio

    • Agilent Technologies

    • Takara Bio

    • GenScript

    • Caribou Biosciences

    • Cellecta

    • Horizon Discovery Group

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Genome Editing

    • Genetic engineering

    • gRNA Database/Gene Librar

    • CRISPR Plasmid

    • Human Stem Cells

    • Genetically Modified Organisms/Crops

    • Cell Line Engineering

    Application:

    • Biotechnology Companies

    • Pharmaceutical Companies

    • Academic Institutes

    • Research and Development Institutes

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 CRISPR/Cas9 Industry Overview

      • 1.1.1 CRISPR/Cas9 Market Scope and Market Segments

      • 1.1.2 CRISPR/Cas9 Industry Characteristics

      • 1.1.3 Global and China CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China CRISPR/Cas9 Production Value and Growth Rate (2017-2028)

    • 1.2 Global CRISPR/Cas9 Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Genome Editing

      • 1.2.2 Genetic engineering

      • 1.2.3 gRNA Database/Gene Librar

      • 1.2.4 CRISPR Plasmid

      • 1.2.5 Human Stem Cells

      • 1.2.6 Genetically Modified Organisms/Crops

      • 1.2.7 Cell Line Engineering

    • 1.3 Global CRISPR/Cas9 Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Biotechnology Companies

      • 1.3.2 Pharmaceutical Companies

      • 1.3.3 Academic Institutes

      • 1.3.4 Research and Development Institutes

    • 1.4 Market Analysis by Region

      • 1.4.1 North America CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global CRISPR/Cas9 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global CRISPR/Cas9 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China CRISPR/Cas9 Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China CRISPR/Cas9 Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global CRISPR/Cas9 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 CRISPR/Cas9 Industry Porter's Five Forces Model Analysis

      • 2.2.3 CRISPR/Cas9 Industry PEST Analysis

    • 2.3 CRISPR/Cas9 Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 CRISPR/Cas9 Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on CRISPR/Cas9 Industry

    Chapter 3 Global and China CRISPR/Cas9 Market, by Manufacturer

    • 3.1 Global and China CRISPR/Cas9 Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China CRISPR/Cas9 Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China CRISPR/Cas9 Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China CRISPR/Cas9 Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China CRISPR/Cas9 Market Top 3 Players

    Chapter 4 Global and China CRISPR/Cas9 Market, by Type (2017-2028)

    • 4.1 CRISPR/Cas9 Market Trend, by Type

    • 4.2 Global CRISPR/Cas9 Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global CRISPR/Cas9 Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global CRISPR/Cas9 Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global CRISPR/Cas9 Price Trend, by Type (2017-2028)

    • 4.3 China CRISPR/Cas9 Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China CRISPR/Cas9 Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China CRISPR/Cas9 Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China CRISPR/Cas9 Price Trend, by Type (2017-2028)

    Chapter 5 Global and China CRISPR/Cas9 Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global CRISPR/Cas9 Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global CRISPR/Cas9 Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global CRISPR/Cas9 Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China CRISPR/Cas9 Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China CRISPR/Cas9 Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China CRISPR/Cas9 Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global CRISPR/Cas9 Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America CRISPR/Cas9 Market Analysis

    • 7.1 North America CRISPR/Cas9 Market, by Type

    • 7.2 North America CRISPR/Cas9 Market, by Application

    • 7.3 North America CRISPR/Cas9 Market Analysis and Forecast, by Country

      • 7.3.1 United States CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe CRISPR/Cas9 Market Analysis

    • 8.1 Europe CRISPR/Cas9 Market, by Type

    • 8.2 Europe CRISPR/Cas9 Market, by Application

    • 8.3 Europe CRISPR/Cas9 Market Analysis and Forecast, by Country

      • 8.3.1 Germany CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC CRISPR/Cas9 Market Analysis

    • 9.1 APAC CRISPR/Cas9 Market, by Type

    • 9.2 APAC CRISPR/Cas9 Market, by Application

    • 9.3 APAC CRISPR/Cas9 Market Analysis and Forecast, by Country

      • 9.3.1 China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa CRISPR/Cas9 Market Analysis

    • 10.1 Latin America, Middle East and Africa CRISPR/Cas9 Market, by Type

    • 10.2 Latin America, Middle East and Africa CRISPR/Cas9 Market, by Application

    • 10.3 Latin America, Middle East and Africa CRISPR/Cas9 Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China CRISPR/Cas9 Company Profiles

      • 11.1 Thermo Fisher Scientific

        • 11.1.1 Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Thermo Fisher Scientific CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.1.3 Thermo Fisher Scientific CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Intellia Therapeutics

        • 11.2.1 Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Intellia Therapeutics CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.2.3 Intellia Therapeutics CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Editas Medicine

        • 11.3.1 Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Editas Medicine CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.3.3 Editas Medicine CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Synthego

        • 11.4.1 Synthego Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Synthego CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.4.3 Synthego CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 CRISPR Therapeutics

        • 11.5.1 CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 CRISPR Therapeutics CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.5.3 CRISPR Therapeutics CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Merck

        • 11.6.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Merck CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.6.3 Merck CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Integrated DNA Technologies (IDT)

        • 11.7.1 Integrated DNA Technologies (IDT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Integrated DNA Technologies (IDT) CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.7.3 Integrated DNA Technologies (IDT) CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 GeneCopoeia

        • 11.8.1 GeneCopoeia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 GeneCopoeia CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.8.3 GeneCopoeia CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Mirus Bio

        • 11.9.1 Mirus Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Mirus Bio CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.9.3 Mirus Bio CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Agilent Technologies

        • 11.10.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Agilent Technologies CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.10.3 Agilent Technologies CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Takara Bio

        • 11.11.1 Takara Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Takara Bio CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.11.3 Takara Bio CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 GenScript

        • 11.12.1 GenScript Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 GenScript CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.12.3 GenScript CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Caribou Biosciences

        • 11.13.1 Caribou Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Caribou Biosciences CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.13.3 Caribou Biosciences CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Cellecta

        • 11.14.1 Cellecta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Cellecta CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.14.3 Cellecta CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Horizon Discovery Group

        • 11.15.1 Horizon Discovery Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Horizon Discovery Group CRISPR/Cas9 Product Profiles, Application and Specification

        • 11.15.3 Horizon Discovery Group CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 CRISPR/Cas9 Industry Investment Prospect and Risk Assessment

    • 12.1 CRISPR/Cas9 Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 CRISPR/Cas9 Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure China CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Global CRISPR/Cas9 Production Value and Growth Rate (2017-2028)

    • Figure China CRISPR/Cas9 Production Value and Growth Rate (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Genome Editing (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Genetic engineering (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of gRNA Database/Gene Librar (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of CRISPR Plasmid (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Human Stem Cells (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Genetically Modified Organisms/Crops (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Cell Line Engineering (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Biotechnology Companies (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Pharmaceutical Companies (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Academic Institutes (2017-2028)

    • Figure Global CRISPR/Cas9 Market Size and Growth Rate of Research and Development Institutes (2017-2028)

    • Figure North America CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR/Cas9 Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global CRISPR/Cas9 Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China CRISPR/Cas9 Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China CRISPR/Cas9 Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China CRISPR/Cas9 Sales Value, by Manufacturer (2021&2022)

    • Table Global and China CRISPR/Cas9 Market Share, by Manufacturer (2021&2022)

    • Figure Global and China CRISPR/Cas9 Market Share, by Manufacturer in 2021

    • Figure Global and China CRISPR/Cas9 Market Share, by Manufacturer in 2022

    • Table Global CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table Global CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure Global CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table Global CRISPR/Cas9 Sales Value, by Type (2017-2028)

    • Table Global CRISPR/Cas9 Sales Value Share, by Type (2017-2028)

    • Figure Global CRISPR/Cas9 Price Trend, by Type (2017-2028)

    • Table China CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table China CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure China CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table China CRISPR/Cas9 Sales Value, by Type (2017-2028)

    • Table China CRISPR/Cas9 Sales Value Share, by Type (2017-2028)

    • Figure China CRISPR/Cas9 Price Trend, by Type (2017-2028)

    • Table Global CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table Global CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure Global CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Table Global CRISPR/Cas9 Sales Value, by Application (2017-2028)

    • Table Global CRISPR/Cas9 Sales Value Share, by Application (2017-2028)

    • Figure Global CRISPR/Cas9 Sales Value Share, by Application (2017-2028)

    • Table China CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table China CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure China CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Table China CRISPR/Cas9 Sales Value, by Application (2017-2028)

    • Table China CRISPR/Cas9 Sales Value Share, by Application (2017-2028)

    • Figure China CRISPR/Cas9 Sales Value Share, by Application (2017-2028)

    • Figure China CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • Figure North America CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • Figure Europe CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • Figure APAC CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa CRISPR/Cas9 Production, Import, Consumption and Export (2017-2022)

    • Table North America CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table North America CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure North America CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table North America CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table North America CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure North America CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure United States CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure United States CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Canada CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Canada CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Mexico CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Table Europe CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table Europe CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure Europe CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table Europe CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table Europe CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure Europe CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure Germany CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Germany CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure UK CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure UK CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure France CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure France CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Italy CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Italy CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Spain CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Spain CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Belgium CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Poland CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Poland CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Russia CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Russia CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Turkey CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Table APAC CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table APAC CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure APAC CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table APAC CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table APAC CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure APAC CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure China CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure China CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Japan CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Japan CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure India CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure India CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure South Korea CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa CRISPR/Cas9 Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Brazil CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure South Africa CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Figure Argentina CRISPR/Cas9 Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina CRISPR/Cas9 Sales Value and Growth Rate (2017-2028)

    • Table Thermo Fisher Scientific Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Thermo Fisher Scientific Product Profiles, Application and Specification

    • Table Thermo Fisher Scientific CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Intellia Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Intellia Therapeutics Product Profiles, Application and Specification

    • Table Intellia Therapeutics CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Editas Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Editas Medicine Product Profiles, Application and Specification

    • Table Editas Medicine CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Synthego Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Synthego Product Profiles, Application and Specification

    • Table Synthego CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CRISPR Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CRISPR Therapeutics Product Profiles, Application and Specification

    • Table CRISPR Therapeutics CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Integrated DNA Technologies (IDT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Integrated DNA Technologies (IDT) Product Profiles, Application and Specification

    • Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GeneCopoeia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GeneCopoeia Product Profiles, Application and Specification

    • Table GeneCopoeia CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mirus Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mirus Bio Product Profiles, Application and Specification

    • Table Mirus Bio CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takara Bio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takara Bio Product Profiles, Application and Specification

    • Table Takara Bio CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GenScript Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GenScript Product Profiles, Application and Specification

    • Table GenScript CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Caribou Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Caribou Biosciences Product Profiles, Application and Specification

    • Table Caribou Biosciences CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cellecta Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cellecta Product Profiles, Application and Specification

    • Table Cellecta CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Horizon Discovery Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Horizon Discovery Group Product Profiles, Application and Specification

    • Table Horizon Discovery Group CRISPR/Cas9 Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.